We had the opportunity to read last issue’s article by Sharfman et al  regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject is a valuable contribution to the study of relevant perioperative complications after hip or knee arthroplasty, and their stepwise approach demonstrated interesting results in patient outcomes . Nevertheless, we would like to contribute some observations that could lead to a better understanding of this article, especially regarding its main conclusion.
Áreas temáticas de ASJC Scopus
- Ortopedia y medicina del deporte